IL6 and COVID-19: Elevated levels of pro-inflammatory cytokines, particularly interleukin-6 (IL-6), interleukin-17 (IL-17), and tumor necrosis factor-alpha (TNF-α), are hallmarks of both CRC progression and COVID-19 severity.